Biotech

All Articles

Bicara, Zenas seek IPOs to drive late-phase assets toward market

.Bicara Rehabs and also Zenas Biopharma have actually offered fresh incentive to the IPO market alon...

Genentech to close cancer immunology analysis department

.Genentech will close its cancer immunology research study team, and also device mind and also popul...

Kezar drops strong lump however to prove its really worth in stage 1 test

.Kezar Life Sciences is actually dropping its unpromising stage 1 solid cyst medicine as the biotech...

Acelyrin drops izokibep, lets go 3rd of personnel

.Even with izokibep maintaining its own newly found winning touch in the center, Acelyrin is actuall...

Rivus' period 2 obesity-related cardiac arrest test strikes endpoint

.Rivus Pharmaceuticals has plumped up the leads of its own fat-busting, muscle-sparing medication ap...

Ovid standstills preclinical work, IV course after soticlestat stop working

.Ovid Therapeutics currently disclosed final month that it was actually trimming back its own head c...

Eli Lilly opens up $700M nucleic acid R&ampD center in Boston ma Seaport

.Eli Lilly has actually opened a $700 thousand R&ampD center in the Boston Port, improving its RNA a...

Boundless Bio makes 'moderate' unemployments five months after $100M IPO

.Just 5 months after safeguarding a $100 million IPO, Vast Bio is actually currently laying off some...

Halda's $126M is going to evolve 'keep and kill' lump medicines

.The initial phases of oncology R&ampD may not be except interesting brand new modalities, as well a...

Lykos 'disappointments' not divulging research study offenses with author

.Psychopharmacology has taken 3 write-ups regarding midstage clinical test information assessing Lyk...